Forbes December 12, 2024
Bruce Japsen

If Walgreens Boots Alliance follows through with a sale to private equity, the company might join other healthcare deals under scrutiny for selling out to such investors.

Earlier this week, a report emerged that Walgreens is considering a sale to private equity firm Sycamore Partners. If the speculation turns into reality, the deal could put the iconic drugstore chain and its thousands of pharmacies and healthcare services under private equity ownership.

The healthcare sector has been ripe for consolidation and sales to private equity in particular have drawn regulatory scrutiny from members of Congress, federal antitrust agencies and state attorneys general.

Influential U.S. Senators earlier this year launched investigations into private equity’s increasing role in owning and operating everything from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices

Share This Article